PharmaCielo Ltd. (PCLOF) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

PharmaCielo Ltd.

PCLOF

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

12M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Nov 2024

12M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Nov 2024

0.08USD

0.00 ( 0.00%)

Market Open

Relative Strenght

Volume Buzz

Earning Acce

Yes

Dist 52w H.

62%

Overview Chart

Quote Panel

Updated October 25, 2024

1W 22.76 % 1M -39.20 % 3M -32.36 % 1Y -40.29 %

Key Metrics

Market Cap
11.89M
Shares Outstanding
141.60M
Share in Float
131.59M
Dividende
0

Earning Date
27 Nov 2024
Price Target
0.084
Average Volume
8335
Beta
2.44

Range
0.063-0.22
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.pharmacielo.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

10.19x

P/S Ratio

-3.65x

P/B Ratio

-3.7

Debt/Equity

-873.6%

Net Margin

$-0.1

EPS

How PCLOF compares to sector?

P/E Ratio

Relative Strength

PCLOF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

-0.02
vs -0.16

Q2.22

N/A

NA
vs -0.04

Q3.22

N/A

-0.02
vs -0.06

Q4.22

N/A

NA
vs NA

Q1.23

N/A

-0.02
vs -0.02

Q2.23

N/A

-0.02
vs NA

Q3.23

N/A

NA
vs -0.02

Q4.23

N/A

-0.04
vs NA

Q1.24

N/A

-0.01
vs -0.02

Q2.24

+100%

NA
vs -0.02

Sales Growth

YoY

Current

Estimates

Q1.22

+78%

1.2M vs 675.3K

Q2.22

+375%

2.1M vs 446K

Q3.22

-2%

475.3K vs 485.2K

Q4.22

+347%

1.5M vs 338.6K

Q1.23

-35%

786.5K vs 1.2M

Q2.23

-92%

159.5K vs 2.1M

Q3.23

-26%

351.7K vs 475.3K

Q4.23

-84%

244K vs 1.5M

Q1.24

-69%

240.3K vs 786.5K

Q2.24

+391%

783.7K vs 159.5K

Return on Equity

QoQ

Q3.22

-56%

-0.56
vs -0.25

Q4.22

-46%

-0.46
vs -0.56

Q1.23

-81%

-0.81
vs -0.46

Q2.23

-101%

-1.01
vs -0.81

Q3.23

-99%

-0.99
vs -1.01

Q4.23

+381%

3.81
vs -0.99

Q1.24

+72%

0.72
vs 3.81

Q2.24

+47%

0.47
vs 0.72

Institutionnal Ownership

Earnings Growth

Latest News

newsfilecorp.com

7 hours ago

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024

newsfilecorp.com

7 hours ago

PharmaCielo Provides Update on Reinstatement for Trading

newsfilecorp.com

7 hours ago

PharmaCielo Announces Issuance of Failure to File Cease Trade Order

newsfilecorp.com

9 hours ago

CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading

newsfilecorp.com

9 hours ago

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024

newsfilecorp.com

16 hours ago

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024

New Feature Coming Soon, Stay Tuned!

Company Description

N/A

10.19x

-3.65x

-3.7

-873.6%

$-0.1

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!